On Tuesday evening, Joanna Rudnick joined the ACLU at Tribeca Cinemas to screen her award-winning documentary film, In the Family, and discuss the patenting of human genes, a practice that has serious ...

WASHINGTON -- The Supreme Court seemed worried Monday about the idea of companies patenting human genes in a case that could profoundly reshape the multibillion-dollar biomedical industry and U.S.

Recently, Dr. James Watson filed an amicus brief opposing gene patents in our lawsuit challenging the patents on two human genes associated with hereditary breast and ovarian cancer. Dr. Watson, along ...

The World Health Organization is creating a working group to study gene editing and the complex ethical, social and safety issues the procedure raises. The panel will help develop "agreed norms and ...

Jeff Bartel is chairman and managing director of Hamptons Group, a private investment and strategic advisory firm headquartered in Miami. Gene editing technology, a major biotechnology advance, is ...

The U.S. Patent and Trademark Office has been awarding patents on human genes for almost 30 years, but opponents of Myriad Genetics Inc.’s patents on two genes linked to an increased risk of breast ...

WASHINGTON -- New guidelines aimed at stopping companies from making frivolous attempts to patent genes before they really have any use for them were issued by the U.S. Patent and Trademark Office on ...

Want a bespoke baby? Check the beauty, brains, or brawn boxes on the embryo order form. Genetic tinkering is no longer science fiction — it’s a market without legal guidelines or societal buy-in. But ...

NEW YORK (Reuters) - Patents on two human genes associated with breast and ovarian cancer should be declared invalid because they stifle the free flow of information and hamper research, lawyers told ...

WASHINGTON (Reuters) - The U.S. Supreme Court on Monday set aside a ruling that said Myriad Genetics Inc could patent two genes linked to breast and ovarian cancers, and ordered further review by a ...